News
Cosmos Holdings Launches New Proprietary Enhanced Dietary Supplement
Cosmos Holdings Launches New Proprietary Enhanced Dietary Supplement CHICAGO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU distribution network, today announced the launch of a new, proprietary enhanced dietary supplement, Bodyguard, a targeted action formula for strengthening the immune system and reducing fatigue. Designed and developed by the company’s wholly owned pharmaceutical subsidiary, Doc ...
Cosmos Holdings Announces December 4th Virtual Bell Ringing to Open Trading on the OTCQX Best Market
Cosmos Holdings Announces December 4th Virtual Bell Ringing to Open Trading on the OTCQX Best Market CHICAGO, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU distribution network, participated in a virtual “Open the Market” on the OTCQX® Best Market today at 9:30 a.m. EST. The virtual bell ringing can be viewed on the ...
COSMOS HOLDINGS BEGINS TRADING ON THE OTCQX® BEST MARKET
CHICAGO, November 25, 2020 -- Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU distribution network, today announced it has qualified to trade on the OTCQX® Best Market; the company has upgraded to OTCQX from the OTCQB® Venture Market and begins trading today on OTCQX under the symbol “COSM.” U.S. investors can find current financial disclosures and Real-Time Level ...
Cosmos Holdings, Inc. Reports Record Third Quarter and Nine-Month Financial Results
Revenue Increases 48%, Gross profit increased 210% to $2.39 million andEarnings Rise over Same 2019 PeriodGenerics and Nutraceuticals Lead Expansion in EuropeRobotic Automations Enhance Margins and Reduce Costs CHICAGO, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the company") (OTCQΒ: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU distribution network, announced today record Third Quarter and Nine-Month results for the period ended September 30, 2020. ...
David Lowenstein Agrees to Join Cosmos Board of Directors
Seasoned Entrepreneur Has Taken Several Companies from Start-Up to IPO and has served on the boards of several NASDAQ and TSXV companies Appointment Follows Recent Board Selection of Peter Goldstein, Director and Principal of PGS Ventures B.V., as Executive Director CHICAGO, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the company") (OTCQB: COSM), an international pharmaceutical wholesaler with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices and an extensive, established EU distribution network, today announced that seasoned entrepreneur David Lowenstein, 58, has agreed ...
Photo
David E. Gutierrez
Head of PR, IR
and Corporate Development

Join our mailing list to stay up to date.

Cosmos-logo